Interleukin 24 in Epidermal Function

白细胞介素 24 对表皮功能的影响

基本信息

  • 批准号:
    7027249
  • 负责人:
  • 金额:
    $ 15.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-03-09 至 2007-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The overall objective of this R21 research plan is to uncover the physiological functions of IL-24, a new cytokine that we recently discovered. IL-24 belongs to the IL-10 family of cytokines. We have identified two heterodimeric EL-24 receptors (IL-22R1/IL-20R2 and IL-20R1 and IL-20R2) which when bound to the ligand leads to STATs activation. Tissue distribution analysis of IL-24 receptor expression indicates that epidermis is one of the major IL-24 target tissues, in contrast to IL-10, which acts mainly on cells from hemopoeitic lineage. We showed that keratinocyres not only expresses IL-24 receptors but also can be activated by IL-24, which leads to mainly StatS activation. Consistently, stat 3 knockout mice were shown to exhibit defects in wound healing. Furthermore, IL-24 expression was found greatly increased during cutaneous wound healing process, and infiltrating mononuclear cells congregating right beneath the wounded epidermis were shown to be the source of IL-24 production. Logically, here we have selected the wound healing process as a model system to explore the physiological functions of IL-24 signaling. We hypothesize that IL-24 may be an important regulator for at least three keratinocyte functions. First, IL-24 produced by infiltrating monocytes may function, in an analogous manner to IL-10 on hematopoietic cells, to inhibit the synthesis of proinflammatory cytokines such as IL-1 and TNF-a by epidermis. In this regard, IL-24 may function as an anti-inflammatory cytokine that signals the attenuation or ultimate termination of inflammatory responses in the skin during the wound healing process. Secondly, IL-24 may function as a signal for keratinocyte proliferation, migration and differentiation during tissue repair. This hypothesis is supported by our finding that IL-24 could substitute IL-3 as a survival and growth factor for murine IL-3 dependent pro-B cells in IL-24 receptor-dependent manner. Thirdly, IL-24 may be part of a more complex cytokine network involved in the wound healing process. We propose the following specific aims to test these hypothesis: Specific Aim 1: To determine the biological functions of IL-24 on keratinocytes by testing if IL-24 can inhibit the production of proinflammatory cytokines, and promote cell proliferation, migration and differentiation. Specific Aim 2: To determine the role of IL-24 in wound healing using mouse skin excision wound model and IL-24 antagonists.
描述(由申请人提供):该R21研究计划的总体目标是揭示IL-24的生理功能,IL-24是我们最近发现的一种新细胞因子。IL-24属于细胞因子的IL-10家族。我们已经鉴定了两种异源二聚体EL-24受体(IL-22 R1/IL-20 R2和IL-20 R1和IL-20 R2),其在与配体结合时导致STAT活化。IL-24受体表达的组织分布分析表明,表皮是IL-24的主要靶组织之一,而IL-10主要作用于造血谱系的细胞。我们发现角质形成细胞不仅表达IL-24受体,而且可以被IL-24激活,这主要导致StatS激活。一致地,stat 3敲除小鼠显示出伤口愈合缺陷。此外,发现IL-24表达在皮肤创伤愈合过程中大大增加,并且显示聚集在创伤表皮正下方的浸润单核细胞是IL-24产生的来源。从逻辑上讲,我们选择伤口愈合过程作为模型系统来探索IL-24信号转导的生理功能。我们推测IL-24可能是至少三种角质形成细胞功能的重要调节因子。首先,由浸润的单核细胞产生的IL-24可以以与造血细胞上的IL-10类似的方式起作用,以抑制表皮合成促炎细胞因子如IL-1和TNF-α。在这方面,IL-24可以作为抗炎细胞因子起作用,其在伤口愈合过程中发出减弱或最终终止皮肤中炎症反应的信号。其次,IL-24可能作为组织修复过程中角质形成细胞增殖、迁移和分化的信号。我们发现IL-24可以以IL-24受体依赖的方式取代IL-3作为小鼠IL-3依赖性pro-B细胞的存活和生长因子,这一假设得到了支持。第三,IL-24可能是参与伤口愈合过程的更复杂的细胞因子网络的一部分。我们提出了以下具体目标来验证这些假设:具体目标1:通过检测IL-24是否可以抑制促炎细胞因子的产生,以及促进细胞增殖、迁移和分化,来确定IL-24对角质形成细胞的生物学功能。具体目的2:使用小鼠皮肤切除伤口模型和IL-24拮抗剂确定IL-24在伤口愈合中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PENG LIANG其他文献

PENG LIANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PENG LIANG', 18)}}的其他基金

Trimer-Tag: A Technology for Producing Trivalent Biologics
Trimer-Tag:一种生产三价生物制剂的技术
  • 批准号:
    8200347
  • 财政年份:
    2011
  • 资助金额:
    $ 15.27万
  • 项目类别:
Interleukin 24 in Epidermal Function
白细胞介素 24 对表皮功能的影响
  • 批准号:
    7229781
  • 财政年份:
    2006
  • 资助金额:
    $ 15.27万
  • 项目类别:
p53 target Genes in Apoptosis
p53 细胞凋亡的靶基因
  • 批准号:
    6861741
  • 财政年份:
    2004
  • 资助金额:
    $ 15.27万
  • 项目类别:
p53 target Genes in Apoptosis
p53 细胞凋亡的靶基因
  • 批准号:
    7191580
  • 财政年份:
    2004
  • 资助金额:
    $ 15.27万
  • 项目类别:
p53 target Genes in Apoptosis
p53 细胞凋亡的靶基因
  • 批准号:
    7025082
  • 财政年份:
    2004
  • 资助金额:
    $ 15.27万
  • 项目类别:
p53 target Genes in Apoptosis
p53 细胞凋亡的靶基因
  • 批准号:
    6718332
  • 财政年份:
    2004
  • 资助金额:
    $ 15.27万
  • 项目类别:
STREAMLINING DIFFERENTIAL DISPLAY TECHNOLOGY
简化差异显示技术
  • 批准号:
    2689867
  • 财政年份:
    1998
  • 资助金额:
    $ 15.27万
  • 项目类别:
STREAMLINING DIFFERENTIAL DISPLAY TECHNOLOGY
简化差异显示技术
  • 批准号:
    2896332
  • 财政年份:
    1998
  • 资助金额:
    $ 15.27万
  • 项目类别:
STREAMLINING DIFFERENTIAL DISPLAY TECHNOLOGY
简化差异显示技术
  • 批准号:
    6173245
  • 财政年份:
    1998
  • 资助金额:
    $ 15.27万
  • 项目类别:
STREAMLINING DIFFERENTIAL DISPLAY TECHNOLOGY
简化差异显示技术
  • 批准号:
    6376631
  • 财政年份:
    1998
  • 资助金额:
    $ 15.27万
  • 项目类别:

相似海外基金

Hedgehog signalling in T-cell differentiation and function
T 细胞分化和功能中的 Hedgehog 信号传导
  • 批准号:
    BB/Y003454/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.27万
  • 项目类别:
    Research Grant
Comparative single-cell analysis of disease-derived stem cells to identify the cell fate defect on the cell differentiation trajectory
对疾病来源的干细胞进行比较单细胞分析,以确定细胞分化轨迹上的细胞命运缺陷
  • 批准号:
    23H02466
  • 财政年份:
    2023
  • 资助金额:
    $ 15.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The role of cell differentiation in colorectal cancer progression
细胞分化在结直肠癌进展中的作用
  • 批准号:
    23K06661
  • 财政年份:
    2023
  • 资助金额:
    $ 15.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dissecting the role of hypoxia in T cell differentiation in cancer
剖析缺氧在癌症 T 细胞分化中的作用
  • 批准号:
    10578000
  • 财政年份:
    2023
  • 资助金额:
    $ 15.27万
  • 项目类别:
Mechanisms mediating human enteroendocrine cell differentiation and function
介导人肠内分泌细胞分化和功能的机制
  • 批准号:
    10739834
  • 财政年份:
    2023
  • 资助金额:
    $ 15.27万
  • 项目类别:
TOX-driven CD8 T cell differentiation and dysfunction in tumors
TOX驱动的肿瘤中CD8 T细胞分化和功能障碍
  • 批准号:
    10586679
  • 财政年份:
    2023
  • 资助金额:
    $ 15.27万
  • 项目类别:
Elucidation of molecular mechanisms of immune cell differentiation of a novel Rab protein in hematopoietic stem cells
阐明造血干细胞中新型Rab蛋白免疫细胞分化的分子机制
  • 批准号:
    23K16122
  • 财政年份:
    2023
  • 资助金额:
    $ 15.27万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
New strategies in cell replacement therapies for diabetes: role of USP7 in iPSC and adult organoids beta cell differentiation
糖尿病细胞替代疗法的新策略:USP7 在 iPSC 和成体类器官 β 细胞分化中的作用
  • 批准号:
    MR/X01813X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 15.27万
  • 项目类别:
    Research Grant
Role of alveolar fibroblasts in extracellular matrix organization and alveolar type 1 cell differentiation
肺泡成纤维细胞在细胞外基质组织和肺泡1型细胞分化中的作用
  • 批准号:
    10731854
  • 财政年份:
    2023
  • 资助金额:
    $ 15.27万
  • 项目类别:
Exhaustive Identification of Essential Genes for Human Taste Cell Differentiation ~Development of a Method for Inducing Differentiation of Taste Buds from ES/iPS Cells~
彻底鉴定人类味觉细胞分化必需基因~开发诱导ES/iPS细胞味蕾分化的方法~
  • 批准号:
    23K09214
  • 财政年份:
    2023
  • 资助金额:
    $ 15.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了